Development and evaluation of a simulation procedure to take into account various assays for the Bayesian dose adjustment of tacrolimus

Therapeutic Drug Monitoring

Volumn 33, Issue 2, 2011, Pages 171-177

  Saint Marcoux, Franck ^a,b   Debord, Jean ^a,b   Parant, François ^c   Labalette, Myriam ^d,e   Kamar, Nassim ^f   Rostaing, Lionel ^f   Rousseau, Annick ^a,b   Marquet, Pierre ^a,b  

^a UNIVERSITY OF LIMOGES   (France)

^b LIMOGES UNIVERSITY HOSPITAL   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d LILLE UNIVERSITY HOSPITAL   (France)

^e UNIV LILLE   (France)

^f TOULOUSE UNIVERSITY HOSPITAL   (France)

Author keywords

Bayesian estimation; immunoassay; pharmacokinetics; tacrolimus; therapeutic drug monitoring

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

AREA UNDER THE CURVE; ARTICLE; BAYES THEOREM; CHEMOLUMINESCENCE; CLINICAL ARTICLE; DISTRIBUTION VOLUME; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; KIDNEY GRAFT; MASS SPECTROMETRY; MATHEMATICAL MODEL; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL;

BAYES THEOREM; CHEMILUMINESCENT MEASUREMENTS; CHROMATOGRAPHY, LIQUID; COMPUTER SIMULATION; DRUG MONITORING; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MASS SPECTROMETRY; TACROLIMUS;

EID: 79953173202     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31820d6ef7     Document Type: Article

References (17)

1. Cross SA, Perry CM. Tacrolimus once-daily formulation: in the prophylaxis of transplant rejection in renal or liver allograft recipients. Drugs. 2007;67:1931-1943. (Pubitemid 47347405)
2. Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit. 2009;31:1-14.
3. Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43: 623-653. (Pubitemid 38981845)
4. Scholten EM, Cremers SC, Schoemaker RC, et al. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Kidney Int. 2005;67:2440-2447. (Pubitemid 41623408)
5. Saint-Marcoux F, Knoop C, Debord J, et al. Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies. Clin Pharmacokinet. 2005;44:1317-1328. (Pubitemid 41832572)
6. Benkali K, Premaud A, Picard N, et al. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet. 2009;48:805-816.
7. Saint-Marcoux F, Debord J, Undre N, et al. Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation. Ther Drug Monit. 2010; 32:129-135.
8. Eupean Medecines Agency. Advagraf: summary of product characteristics. Available at: http://www.emea.europea.eu. Accessed February 9, 2011.
9. Lunn DJ, Best N, Thomas A, et al. Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Pharmacodyn. 2002;29:271-307. (Pubitemid 35333143)
10. Jeliffe RW, Schumitzky A, Van Guilder M, et al. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control. Ther Drug Monit. 1993;15: 380-393. (Pubitemid 23297240)
11. Gelman A, Carlin JB, Stern HS, et al. Bayesian Data Analysis. 2nd ed. Boca Raton, FL: Chapman & Hall/CRC; 2004.
12. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1: 307-310. (Pubitemid 16134762)
13. Matsumoto M, Nishimura T. Mersenne twister: a 623-dimensionally equidistributed uniform pseudorandom number generator. ACM Trans Mod Comp Simul. 1998;8:3-30. Available at: http://www.math.sci.hiroshima- u.ac.jp/;m-mat/MT/ emt.html.
14. Press WH, Teukolsky SA, Vetterling WT, et al. Numerical Recipes. The Art of Scientific Computing. 2nd ed. New York: Cambridge University Press; 1992.
15. Sheiner LB, Beal SL. Some suggestions for measuring predictive performance. J Pharmacokinet Biopharm. 1981;9:503-512.
16. Cotton C, Johnston A, Holt DW. A comparison of tacrolimus assays: HPLC/ MS versus immunoassay [abstract]. Ther Drug Monit. 2007;29:508.
17. Moes DJ, Press RR, de Fijter, et al. de Fijter, et al. Liquid chromatography- tandem mass spectrometry outperforms fluorescence polarization immunoassay in monitoring everolimus therapy in renal transplantation. Ther Drug Monit. 2010;32:413-419.